132 related articles for article (PubMed ID: 12788077)
21. Yeast surviving factor Svf1 as a new interacting partner, regulator and in vitro substrate of protein kinase CK2.
Masłyk M; Kochanowicz E; Zieliński R; Kubiński K; Hellman U; Szyszka R
Mol Cell Biochem; 2008 May; 312(1-2):61-9. PubMed ID: 18265947
[TBL] [Abstract][Full Text] [Related]
22. Acetoxymethyl Ester of Tetrabromobenzimidazole-Peptoid Conjugate for Inhibition of Protein Kinase CK2 in Living Cells.
Viht K; Saaver S; Vahter J; Enkvist E; Lavogina D; Sinijärv H; Raidaru G; Guerra B; Issinger OG; Uri A
Bioconjug Chem; 2015 Dec; 26(12):2324-35. PubMed ID: 26559659
[TBL] [Abstract][Full Text] [Related]
23. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
[TBL] [Abstract][Full Text] [Related]
24. Features and potentials of ATP-site directed CK2 inhibitors.
Sarno S; Salvi M; Battistutta R; Zanotti G; Pinna LA
Biochim Biophys Acta; 2005 Dec; 1754(1-2):263-70. PubMed ID: 16198160
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of human La protein at Ser 366 by casein kinase II contributes to hepatitis B virus replication and expression in vitro.
Tang J; Zhang ZH; Huang M; Heise T; Zhang J; Liu GL
J Viral Hepat; 2013 Jan; 20(1):24-33. PubMed ID: 23231081
[TBL] [Abstract][Full Text] [Related]
26. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
27. Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1.
Chi LM; Yu JS; Chang YS
Biochem Biophys Res Commun; 2002 Jun; 294(3):586-91. PubMed ID: 12056807
[TBL] [Abstract][Full Text] [Related]
28. Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1.
Kubiński K; Masłyk M; Orzeszko A
Mol Cell Biochem; 2017 Feb; 426(1-2):195-203. PubMed ID: 27909846
[TBL] [Abstract][Full Text] [Related]
29. Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.
Battistutta R; De Moliner E; Sarno S; Zanotti G; Pinna LA
Protein Sci; 2001 Nov; 10(11):2200-6. PubMed ID: 11604527
[TBL] [Abstract][Full Text] [Related]
30. Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity.
Cozza G; Zanin S; Sarno S; Costa E; Girardi C; Ribaudo G; Salvi M; Zagotto G; Ruzzene M; Pinna LA
Biochem J; 2015 Nov; 471(3):415-30. PubMed ID: 26349539
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect and its kinetic analysis of tyrphostin AG1478 on recombinant human protein kinase CK2 holoenzyme.
Liu XG; Liang NC
Acta Pharmacol Sin; 2002 Jun; 23(6):556-61. PubMed ID: 12060532
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect and kinetic analysis of sodium quercetin-7,4'-disulphate on recombinant human protein kinase CK2 holoenzyme].
Liu XG; Liang NC; Liu W; She J; Mo LE
Yao Xue Xue Bao; 2002 Mar; 37(3):165-8. PubMed ID: 12579753
[TBL] [Abstract][Full Text] [Related]
33. The protein kinase 60S is a free catalytic CK2alpha' subunit and forms an inactive complex with superoxide dismutase SOD1.
Abramczyk O; Zień P; Zieliński R; Pilecki M; Hellman U; Szyszka R
Biochem Biophys Res Commun; 2003 Jul; 307(1):31-40. PubMed ID: 12849977
[TBL] [Abstract][Full Text] [Related]
34. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2.
Battistutta R; Sarno S; De Moliner E; Papinutto E; Zanotti G; Pinna LA
J Biol Chem; 2000 Sep; 275(38):29618-22. PubMed ID: 10882732
[TBL] [Abstract][Full Text] [Related]
35. Toward the rational design of protein kinase casein kinase-2 inhibitors.
Sarno S; Moro S; Meggio F; Zagotto G; Dal Ben D; Ghisellini P; Battistutta R; Zanotti G; Pinna LA
Pharmacol Ther; 2002; 93(2-3):159-68. PubMed ID: 12191608
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase CK2 phosphorylates the cell cycle regulatory protein Geminin.
Kulartz M; Hiller E; Kappes F; Pinna LA; Knippers R
Biochem Biophys Res Commun; 2004 Mar; 315(4):1011-7. PubMed ID: 14985113
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA
Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539
[TBL] [Abstract][Full Text] [Related]
38. Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.
Wąsik R; Wińska P; Poznański J; Shugar D
PLoS One; 2012; 7(11):e48898. PubMed ID: 23155426
[TBL] [Abstract][Full Text] [Related]
39. Structure-guided discovery of adenosine triphosphate-competitive casein kinase 2 inhibitors.
Patel S; Vyas VK; Sharma M; Ghate M
Future Med Chem; 2023 Jun; 15(11):987-1014. PubMed ID: 37307219
[TBL] [Abstract][Full Text] [Related]
40. [Inhibitory effect of AG1109 on recombinant human protein kinase CK2 holoenzyme].
Liu XG; Liang NC
Ai Zheng; 2002 Feb; 21(2):153-7. PubMed ID: 12479065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]